ZLAB(ZLAB)
ZLAB
Q4 2026 EPS Estimate
$-0.56
Nov 5, 2026 · Reports before open
Revenue Estimate
$109M
FY2030E EPS$0.48
Analyst Sentiment
Wall St. Consensus
Buy10 analysts·Moderate coverage
73
Score
9 Buy (90%)1 Hold (10%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
990%
Hold
110%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$35.00
+37.5%
Consensus
$52.50
+106.2%
Bull
$75.00
+194.6%
12-Month Target Range10 analysts
$35.00$52.50$75.00
Current $25.46Consensus
Current Price
$25.46
Upside to Consensus
$27.04
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+21.05%
EPS—
FY2028
Rev+35.95%
EPS—
FY2029
Rev+37.37%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $427M | $517M | $703M | $966M | $1.10B |
| Low | $398M | $495M | $519M | $845M | $958M |
| High | $457M | $539M | $832M | $1.14B | $1.29B |
| EBITDA Avg | $-220M | $-170M | $-115M | $25M | $125M |
| Low | $-269M | $-270M | $-229M | $20M | $114M |
| High | $-177M | $-111M | $-44M | $29M | $141M |
| EBIT Avg | $-240M | $-196M | $-149M | $-19M | $69M |
| Low | $-289M | $-295M | $-263M | $-25M | $58M |
| High | $-196M | $-137M | $-77M | $-16M | $85M |
| Net Income Avg | $-242M | $-198M | $-151M | $-22M | $53M |
| Low | $-291M | $-298M | $-265M | $-27M | $44M |
| High | $-199M | $-139M | $-80M | $-18M | $65M |
| EPS Avg | $-2.23 | $-2.13 | $-1.43 | $-0.20 | $0.48 |
| Low | $-2.66 | $-2.72 | $-2.42 | $-0.25 | $0.40 |
| High | $-1.82 | $-1.27 | $-0.73 | $-0.17 | $0.59 |
| Analysts (Rev / EPS) | 8 / 7 | 12 / 7 | 13 / 5 | 11 / 1 | 6 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $109M | $114M | $117M | $123M | $129M | $141M |
| Low | $98M | $100M | $107M | $113M | $119M | $130M |
| High | $120M | $127M | $128M | $134M | $141M | $154M |
| EBITDA Avg | $-57M | $-63M | $-53M | $-51M | $-49M | $-43M |
| Low | $-65M | $-109M | $-60M | $-58M | $-55M | $-49M |
| High | $-50M | $-40M | $-46M | $-45M | $-43M | $-38M |
| EBIT Avg | $-61M | $-67M | $-58M | $-56M | $-54M | $-49M |
| Low | $-69M | $-114M | $-65M | $-63M | $-61M | $-55M |
| High | $-55M | $-45M | $-51M | $-50M | $-48M | $-44M |
| Net Income Avg | $-63M | $-69M | $-59M | $-58M | $-56M | $-51M |
| Low | $-71M | $-115M | $-66M | $-64M | $-63M | $-57M |
| High | $-56M | $-47M | $-53M | $-51M | $-50M | $-45M |
| EPS Avg | $-0.56 | $-0.62 | $-0.53 | $-0.52 | $-0.50 | $-0.46 |
| Low | $-0.63 | $-1.03 | $-0.59 | $-0.58 | $-0.56 | $-0.51 |
| High | $-0.51 | $-0.42 | $-0.47 | $-0.46 | $-0.45 | $-0.41 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 6 | 2 / 2 | 2 / 2 | 2 / 2 | 2 / 2 |
